NeurosciencebioRxivPreprint
GLP-1 receptor agonism ameliorates Parkinsons disease through modulation of neuronal insulin signalling and glial suppression
Dilan S. Athauda, James R Evans, Laura Mahoney‐Sanchez…·Sonia Gandhi
This study shows GLP-1R agonism improves Parkinson's disease by restoring neuronal insulin signaling and reducing glial inflammation, with clinical benefits in patients with higher baseline MAPK expression.
7 citations